Related Experiment Videos
Immunopathogenesis of viral hepatitis
1Division of Gastroenterology and Hepatology, Medical School of Hannover, Germany.
Bailliere'S Clinical Gastroenterology
|September 1, 1996
Summary
Viral hepatitis affects over 500 million globally. The immune system
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Viral hepatitis, affecting over 500 million worldwide, presents a spectrum of liver disease from acute to cirrhosis.
- Disease outcomes depend on viral properties and host immune system interactions.
- The immune response is critical for viral clearance and pathogenesis in hepatitis B and C.
Purpose of the Study:
- To detail the immune response in acute and chronic hepatitis B and C virus infections.
- To compare immune mechanisms underlying different clinical outcomes of HBV and HCV.
- To discuss implications for developing immunomodulatory vaccines for chronic viral hepatitis.
Main Methods:
- Detailed description of immune responses in acute and chronic hepatitis B and C.
- Analysis of cytotoxic T lymphocyte (CTL) responses in HBV and HCV infections.
- Comparison of immunological and viral factors influencing disease progression.
Main Results:
- Acute hepatitis B (HBV) shows a vigorous HBV-specific CTL response, crucial for disease resolution.
- Chronic hepatitis B lacks this readily detectable CTL response, with persistence suggesting protection from reactivation.
- Hepatitis C virus (HCV) establishes chronic disease despite a polyclonal immune response, indicating distinct viral and immune mechanisms.
Conclusions:
- HBV-specific CTL response mediates resolution and long-term protection in hepatitis B.
- Distinct immunological and viral factors contribute to the chronic nature of HCV infection.
- Understanding these differences is key for developing effective immunomodulatory vaccines for chronic viral hepatitis.